Lamotrigine Tablet, Extended Release
Product Images NDC 70771-1516

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70771-1516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 01)

Lamotrigine Extended-Release Tablets, USP 25 mg oral tablets packaging label from Zydus Lifesciences Limited. The package contains 30 tablets for prescription use only and includes dosage warnings, storage instructions, and manufacturer details (Cadila Healthcare Ltd, Ahmedabad, India). The label features branding, NDC 70771-1514-3, and cautions about verifying product dispensed and safety seal integrity.*

FDA Label Image

50 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 02)

Lamotrigine Extended-Release Tablets, USP 50 mg, oral tablet, extended-release, labeled for once-a-day use. The carton label shows 30 tablets per package, manufactured by Cadila Healthcare Ltd., Ahmedabad, India, and labeled by Zydus Pharmaceuticals. The label includes dosage form, strength, NDC 70771-1515-3, and cautions about the safety seal and storage.*

FDA Label Image

100 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 03)

Label for Lamotrigine Extended-Release Tablets USP 100 mg, oral tablet in a 30-tablet package by Zydus Lifesciences Limited. It features the product name, strength, and dosage form prominently, along with an image of a tan, round tablet imprinted with '981'. Additional label details include storage instructions, caution statements, and manufacturer information from Cadila Healthcare Ltd., Ahmedabad, India.*

FDA Label Image

200 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 04)

Label for Lamotrigine Extended-Release Tablets USP 200 mg oral tablets by Zydus Lifesciences Limited. The label includes NDC 70771-1517-3, caution to verify product dispense, pharmacist instructions to dispense medication guide, and the tablet imprint '982'. The package contains 30 tablets for prescription use only, manufactured by Cadila Healthcare Ltd., Ahmedabad, India.*

FDA Label Image

250 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 05)

Label for Lamotrigine Extended-Release Tablets USP 250 mg, once a day oral tablets by Zydus Lifesciences Limited. The label indicates 30 tablets per package, includes caution and pharmacist dispensing instructions, storage conditions (20º to 25ºC), and manufacturer details (Cadila Healthcare Ltd., Ahmedabad, India). The product is for prescription use only with the NDC 70771-1518-3.*

FDA Label Image

300 mg Label (717d1fe1 5c2b 4e10 A4ac 12aed4ed13d4 06)

Label for Lamotrigine Extended-Release Tablets, USP 300 mg from Zydus Lifesciences Limited. The label indicates 30 tablets per package, Rx only, with manufacturer details as Cadila Healthcare Ltd, Ahmedabad, India. It includes dosage form as extended-release film-coated tablets and storage instructions, with a barcode and NDC 70771-1519-3 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.